Predictive and fluorescent nanosensing experimental methods for evaluating anthrax protective antigen and lethal
Somayyeh Dabbagh Sadeghpour1, Farrokh Karimi1, Houshang Alizadeh2
1Department of Biotechnology, Faculty of Science, University of Maragheh, P.O. Box 55181-83111, Maragheh, Iran.
International Journal of Biological Macromolecules
|May 29, 2020
Summary
Researchers explored the interaction between anthrax protective antigen domain 4 (PAD4) and lethal factor domain 1 (LFD1). Novel biosensing platforms confirmed PAD4-LFD1 interactions, offering potential for new medical diagnostics and therapeutics.
Area of Science:
- Biochemistry
- Nanotechnology
- Medical Diagnostics
Background:
- The interaction between anthrax protective antigen domain 4 (PAD4) and lethal factor domain 1 (LFD1) is crucial for developing new medical tools.
- Understanding these specific interactions is key for designing novel diagnostic and therapeutic systems.
Purpose of the Study:
- To theoretically and experimentally investigate the interaction between PAD4 and LFD1.
- To validate the use of PAD4-LFD1 interactions in advanced biosensing platforms.
Main Methods:
- Computational prediction using CLusPro server and Dimplot software.
- Experimental validation using Magnetic Bead (MB) and Multi-Walled Carbon Nanotubes (MWCNTs) based biosensing platforms.
- Protein expression and purification of PAD4 and LFD1 in Escherichia coli.
Main Results:
- Theoretical analysis identified interaction sites between PAD4 and LFD1 on loop regions.
- Magnetic bead-based assay confirmed PAD4-LFD1 interaction via magnetic sedimentation and fluorescence.
- MWCNT-based assay demonstrated fluorescence recovery upon LFD1 addition, indicating interaction and separation from MWCNTs.
Conclusions:
- The study successfully demonstrated the interaction between PAD4 and LFD1 using both computational and experimental methods.
- The developed biosensing platforms utilizing PAD4-LFD1 interaction show promise for medical applications.
- This interaction serves as a valuable model for future diagnostic and therapeutic advancements in medicine.


